Eosinophilic Esophagitis EoE
You may be eligible for a clinical research study if you have a confirmed diagnosis of eosinophilic esophagitis (EoE), eosinophilic gastritis and/or
eosinophilic duodenitis (EG/EoD).
ClinicalTrials.gov Study Details
Eosinophilic Esophagitis (EoE) (FLUTE-2) (FLUTE-2)
Adare Pharmaceuticals US, LP Protocol Title: Fluticasone propionate Oral Dispersible Tablet Formulation in Eosinophilic Esophagitis: A Two-Part, Randomized, Double-blind, Placebo-Controlled Study of APT-1011 in Adult and Adolescent Subjects with Eosinophilic Esophagitis Protocol Number: SP-1011-003 Short Title: FLUTE-2
Eosinophilic Esophagitis (KRYPTOS)
Clinical Research Protocol AK002-014 A Phase 2/3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of AK002 in Adult and Adolescent Patients with Active Eosinophilic Esophagitis